79355266 - DECOMED BIOLOGICAL IDENTITY

Information

  • Trademark
  • 79355266
  • Serial Number
    79355266
  • Filing Date
    September 29, 2022
    2 years ago
  • Transaction Date
    May 07, 2024
    8 months ago
  • Status Date
    March 05, 2024
    10 months ago
  • Location Date
    March 05, 2024
    10 months ago
  • Status Code
    602
  • Current Location
    TMO LAW OFFICE 110 - EXAMINING ATTORNEY ASSIGNED
    Employee Name
    NADELMAN, ANDREA KOYNE
  • Law Office Assigned Location Code
    M10
  • Owners
Mark Drawing Code
3
Mark Identification
DECOMED BIOLOGICAL IDENTITY
Case File Statements
  • GS0051: Cells for medical use; stem cells; living cells for medical use; biological implants; surgical implants comprised of living tissues; surgical implants grown from stem cells [living tissues]; implants comprising living tissue; surgical implants grown from stem cells; implants for guided tissue regeneration; arterial grafts; skin grafts; transplants [living tissues]; implantable textile material to encourage the growth of tissue; implantable materials for use in guided tissue regeneration; bone void fillers consisting of natural materials; bone void fillers comprised of living tissues; scapulars for surgical purposes; processed human donor skin for the replacement of soft tissue; bone fillers consisting of living materials; biological tissue for implantation; human allograft tissue
  • GS0441: Fitting of prosthetic devices; fitting of prosthetics; fitting of artificial limbs, prosthetic devices and prostheses; medical services; medical treatment services; medical analysis for the diagnosis and treatment of persons; medical clinic services; advisory services relating to medical services; medical counseling; human healthcare services
  • GS0101: Biodegradable prostheses; implanted prosthesis; artificial limbs; medical devices for closing wounds; prosthetics and artificial implants
  • GS0421: Design of prostheses; design and development of prostheses; development of prostheses; scientific research and development; research and development of vaccines and medicines; pharmaceutical research and development; research and development in the field of biotechnology; research and development in the pharmaceutical and biotechnology fields; research and development in the field of diagnostic preparations; consultancy relating to research and development in the field of therapeutics; consultancy relating to pharmaceutical research and development; research and development services in the field of antibody technology; provision of information and data relating to medical and veterinary research and development; medical and pharmacological research services
Case File Event Statements
  • 11/22/2022 - 2 years ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 7/14/2023 - a year ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 11/17/2022 - 2 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 11/18/2022 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 7/17/2023 - a year ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 7/18/2023 - a year ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 8/17/2023 - a year ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 3/5/2024 - 10 months ago
    12 - ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Type: MAB2
  • 4/17/2024 - 9 months ago
    14 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 4/17/2024 - 9 months ago
    13 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR
  • 5/7/2024 - 8 months ago
    15 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX
  • 8/17/2023 - a year ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 9/4/2023 - a year ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 3/5/2024 - 10 months ago
    10 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Type: ABN2
  • 3/5/2024 - 10 months ago
    11 - ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Type: MAB2